Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityUAN / CVR Partners, LP (126633106)
President and CEOPYTOSH MARK A
IndustryAgricultural Chemicals
Institutional Owners61
Institutional Shares37,050,327 - 32.71%
Common Shares Outstanding113,282,973 shares (as of 2018-03-31)
Institutional Value$ 121,008,000 USD

Institutional Stock Ownership and Shareholders()

UAN / CVR Partners, LP Institutional Ownership

CVR Partners, LP (NYSE:UAN) has 61 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,050,327 shares. Largest shareholders include Raging Capital Management, LLC, Goldman Sachs Group Inc, Blackstone Group L.P., Morgan Stanley, Barclays Plc, JP Morgan Chase & Co, FMR LLC / Fidelity, Nwq Investment Management Company, Llc, HITE Hedge Asset Management LLC, and Glendon Capital Management LP.
CVR Partners, LP (NYSE:UAN) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/uan"><img src="https://images.fintel.io/us-uan-so.png" alt="UAN / CVR Partners, LP Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR LPL Financial LLC 139,464 144,216 3.41 457 469 2.63
2018-05-04 13F-HR BABSON CAPITAL MANAGEMENT LLC 126,319 126,319 0.00 414 411 -0.72
2018-05-15 13F-HR Raging Capital Management, LLC 9,572,033 9,572,033 0.00 31,396 31,109 -0.91
2018-05-15 13F-HR CREDIT SUISSE AG/ 67,500 203,900 202.07 222 663 198.65
2018-05-01 13F-HR PEKIN SINGER STRAUSS ASSET MANAGEMENT /IL 10,000 10,000 0.00 33 32 -3.03
2018-05-14 13F-HR FMR LLC / Fidelity 1,058,200 1,058,200 0.00 3,471 3,439 -0.92
2018-05-15 13F-HR Anchor Bolt Capital, LP 1,177,961 0 -100.00 3,864 0 -100.00
2018-05-01 13F-HR Prime Capital Investment Advisors, Llc 22,000 15,000 -31.82 72 49 -31.94
2018-05-01 13F-HR WEDBUSH SECURITIES INC 13,321 12,148 -8.81 44 39 -11.36
2018-05-14 13F-HR Glendon Capital Management LP 2,258,923 546,279 -75.82 7,409 1,775 -76.04
2018-04-20 13F-HR Seacrest Wealth Management, Llc 912 912 0.00 3 3 0.00
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 98,527 17,965 -81.77 323 58 -82.04
2018-05-10 13F-HR JP Morgan Chase & Co 175,771 2,041,696 1,061.57 577 6,636 1,050.09
2018-05-10 13F-HR Myda Advisors Llc 58,812 0 -100.00 193 0 -100.00
2018-05-11 13F-HR Cutler Group LP 17,901 5,512 -69.21 58 17 -70.69
2018-05-11 13F-HR CITADEL ADVISORS LLC 17,965 58
2018-04-26 13F-HR SIMPLEX TRADING, LLC 31,642 1,709 -94.60 103 5 -95.15
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 369,433 440,154 19.14 1,211 1,431 18.17
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 54,700 86,600 58.32 179 281 56.98
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 170,100 170,100 0.00 558 553 -0.90
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 29,979 29,479 -1.67 98 96 -2.04
2018-05-14 13F-HR MORGAN STANLEY 942,984 2,872,537 204.62 3,092 9,336 201.94
2018-04-17 13F-HR Sawyer & Company, Inc 4,315 4,315 0.00 14 14 0.00
2018-05-04 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 473 473 0.00 2 2 0.00
2018-05-15 13F-HR SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 16,600 54
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 23,500 0 -100.00 77 0 -100.00
2018-05-14 13F-HR Nuveen Fund Advisors, LLC 38,395 35,499 -7.54 126 115 -8.73
2018-05-15 13F-HR Credit Capital Investments LLC 472,274 472,274 0.00 1,549 1,535 -0.90
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 0 4,500 0 15
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 25,400 30,700 20.87 83 100 20.48
2018-05-11 13F-HR SEI INVESTMENTS CO 0 5,317 0 17
2018-05-08 13F-HR US BANCORP \DE\ 1,540 1,540 0.00 5 5 0.00
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 82,558 82,358 -0.24 271 268 -1.11
2018-05-15 13F-HR TWO SIGMA SECURITIES, LLC 12,223 0 -100.00 40 0 -100.00
2018-04-26 13F-HR SIMPLEX TRADING, LLC Call 25 3 -88.00 0 0
2017-01-13 13F-HR MetLife Securities, Inc 4,665 4,775 2.36 25 29 16.00
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 2,866 0 9
2018-05-15 13F-HR Jefferies Group LLC 0 175,000 0 569
2018-04-23 13F-HR Advisory Services Network, LLC 175 0 -100.00 1 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC Put 18,200 59
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 6,563 5,625 -14.29 22 18 -18.18
2018-05-07 13F-HR Greenwich Investment Management, Inc. 22,249 23,099 3.82 72 75 4.17
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 18,582 0 -100.00 61 0 -100.00
2018-05-11 13F-HR SevenBridge Financial Group, LLC 944 944 0.00 3 3 0.00
2018-05-15 13F-HR IndexIQ Advisors LLC 15,201 15,419 1.43 50 50 0.00
2018-05-14 13F-HR Virtu Financial LLC 157,391 23,876 -84.83 516 78 -84.88
2018-05-15 13F-HR Ahrens Investment Partners Llc 19,980 18,050 -9.66 66 58 -12.12
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 115,109 174,118 51.26 377 566 50.13
2017-01-23 SC 13D/A RENTECH, INC. 7,187,630
2018-04-12 13F-HR Integrated Investment Consultants, LLC 1,000 3
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 99,297 214,524 116.04 326 697 113.80
2018-05-15 13F-HR Advisor Group, Inc. 3,217 3,555 10.51 10 11 10.00
2018-05-15 13F-HR UBS Group AG 61,919 86,110 39.07 203 279 37.44
2018-05-15 13F-HR BARCLAYS PLC Put 2,300 12,400 439.13 8 40 400.00
2018-05-09 13F-HR IFP Advisors, Inc 8,055 7,937 -1.46 26 26 0.00
2018-04-26 13F-HR SIMPLEX TRADING, LLC Put 152 28 -81.58 27 1 -96.30
2018-05-14 13F-HR/A CITADEL ADVISORS LLC Put 37,000 18,200 -50.81 121 59 -51.24
2018-04-18 13F-HR REGIONS FINANCIAL CORP 8,120 8,120 0.00 27 26 -3.70
2018-05-10 13F-HR Stockman Asset Management 11,180 11,180 0.00 37 36 -2.70
2018-05-15 13F-HR BARCLAYS PLC 261,584 2,229,730 752.40 858 7,247 744.64
2018-05-14 13F-HR Quinn Opportunity Partners LLC 84,430 84,430 0.00 277 274 -1.08
2018-05-14 13F-HR Bollard Group LLC 424 424 0.00 1 1 0.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 5,358,106 8,125,946 51.66 17,575 26,409 50.26
2018-05-01 13F-HR MARCO INVESTMENT MANAGEMENT LLC 0 23,528 0 76
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 1,001 3
2018-05-15 13F-HR Blackstone Group L.P. 9,053,827 5,307,821 -41.37 29,697 17,250 -41.91
2018-05-15 13F-HR DEUTSCHE BANK AG\ 98,795 3,702 -96.25 323 11 -96.59
2018-05-14 13F-HR NWQ INVESTMENT MANAGEMENT COMPANY, LLC 977,525 967,190 -1.06 3,206 3,143 -1.97
2018-04-20 13F-HR America First Investment Advisors, LLC 255 255 0.00 1 1 0.00
2018-05-03 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 0 1,804 0 6
2018-05-15 13F-HR CNA FINANCIAL CORP 502,664 502,664 0.00 1,649 1,634 -0.91
2017-01-27 13F-HR Strategic Income Management, LLC 213,218 213,218 0.00 1,130 1,281 13.36
2018-05-15 13F-HR BARCLAYS PLC Call 800 5,600 600.00 3 18 500.00
2018-04-18 13F-HR FORBES J M & CO LLP 14,900 14,900 0.00 49 48 -2.04
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 19,755 16,570 -16.12 64 54 -15.62
2018-05-02 13F-HR Global X Management CO LLC 27,202 27,202 0.00 89 88 -1.12
2018-05-11 13F-HR HITE Hedge Asset Management LLC 1,162,399 849,244 -26.94 3,813 2,760 -27.62
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 7,586 0 -100.00 25 0 -100.00

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Tracking Carl Icahn's Portfolio - Q1 2018 Update

2018-05-21 seekingalpha
This article is part of a series that provides an ongoing analysis of the changes made to Carl Icahn's 13F portfolio on a quarterly basis. It is based on Icahn's regulatory 13F Form filed on 05/15/2018. Please visit our Tracking Carl Icahn's Portfolio series to get an idea of his investment philosophy and our previous update for the fund's moves during Q4 2017. (212-6)

MLPs: Buy After Distribution Cuts Or Run Away?

2018-05-17 seekingalpha
Many income investors sell on cuts to dividends and distributions. Other investors take a vulture-like approach and buy. Who is right? (27-0)

Icahn Enterprises' (IEP) CEO Keith Cozza on Q1 2018 Results - Earnings Call Transcript

2018-05-03 seekingalpha
Good morning and welcome to the Icahn Enterprises LP Q1 2018 Earnings Call with Jesse Lynn, General Counsel; Keith Cozza, President and CEO and SungHwan Cho, Chief Financial Officer. I would now like to hand over the call to Jesse Lynn who will read the opening statement. (14-1)

CVR Partners' (UAN) Q1 Earnings Lag Estimates, Sales Fall

2018-04-27 zacks
CVR Partners, LP (UAN - Free Report) posted a loss of $19 million or 17 cents per share in the first quarter of 2018, wider than a loss of $10 million or 9 cents per share it logged a year ago. The reported loss per share was also wider than the Zacks Consensus Estimate of a loss of 13 cents. CVR Partners raked in net sales of $80 million, down around 5.9% year over year. The company’s Coffeyville fertilizer plant performed well during the quarter, recording on-stream rates of 100% for gasification, 99. (16-0)

CVR Partners' (UAN) Q1 Earnings Miss Estimates, Sales Down

2018-04-26 zacks
CVR Partners, LP (UAN - Free Report) makes and markets nitrogen fertilizers including ammonia and urea ammonium nitrate (“UAN”) in the United States. Earnings CVR Partners reported net loss of 17 cents per share for the first quarter. The figure was wider than the Zacks Consensus Estimate of a loss of 13 cents. Revenues CVR Partners posted first-quarter net sales of $79.9 million, down 6.3% year over year. (7-0)

CUSIP: 126633106